Torsemide Fast Dissolving Tablets: Development, Optimization Using Box–Bhenken Design and Response Surface Methodology, In Vitro Characterization, and Pharmacokinetic Assessment View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-08

AUTHORS

Ahmed A. El-Shenawy, Mahmoud M. Ahmed, Heba F. Mansour, Saleh Abd El Rasoul

ABSTRACT

The present study planed to develop new fast dissolving tablets (FDTs) of torsemide. Solid dispersions (SDs) of torsemide and sorbitol (3:1) or polyvinylpyrrolidone (PVP) k25 were prepared. The prepared SDs were evaluated for in-vitro dissolution. Fourier transform infrared spectroscopy and differential scanning calorimetry for SDs revealed no drug/excipient interactions and transformation of torsemide to the amorphous form. Torsemide/sorbitol SD was selected for formulation of torsemide FDTs by direct compression method. Box-Bhenken factorial design was employed to design 15 formulations using croscarmellose sodium and crospovidone at different concentrations. The response surface methodology was used to analyze the effect of changing these concentrations (independent variables) on disintegration time (Y1), percentage friability (Y2), and amount torsemide released at 10 min. The physical mixtures of torsemide and the used excipients were evaluated for angle of repose, Hausner's ratio, and Carr's index. The prepared FDTs tablets were evaluated for wetting and disintegration time, weight variation, drug content, percentage friability, thickness, hardness, and in vitro release. Based on the in-vitro results and factorial design characterization, F10 and F7 were selected for bioavailability studies following administration to Albino New Zealand rabbits. They showed significantly higher C max and (AUC0-12) and shorter T max than those obtained after administration of the corresponding ordinary commercial Torseretic ® tablets. Stability study was conducted for F10 that showed good stability upon storage at 30°C/75% RH and 40°C/75% RH for 3 months. More... »

PAGES

2168-2179

Identifiers

URI

http://scigraph.springernature.com/pub.10.1208/s12249-016-0697-6

DOI

http://dx.doi.org/10.1208/s12249-016-0697-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001551151

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28050711


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0306", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Chemistry (incl. Structural)", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Availability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calorimetry, Differential Scanning", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carboxymethylcellulose Sodium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Compounding", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Excipients", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pharmaceutic Aids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Povidone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rabbits", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Solubility", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sorbitol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Spectroscopy, Fourier Transform Infrared", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfonamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sweetening Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tablets", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Torsemide", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Al Azhar University", 
          "id": "https://www.grid.ac/institutes/grid.411303.4", 
          "name": [
            "Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt"
          ], 
          "type": "Organization"
        }, 
        "familyName": "El-Shenawy", 
        "givenName": "Ahmed A.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sohag University", 
          "id": "https://www.grid.ac/institutes/grid.412659.d", 
          "name": [
            "Department of Pharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, Sohag University, Sohag, Egypt"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ahmed", 
        "givenName": "Mahmoud M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Minia University", 
          "id": "https://www.grid.ac/institutes/grid.411806.a", 
          "name": [
            "Department of Pharmaceutics, Faculty of Pharmacy, Minia University, P.O.Box 61111, Minia, Egypt"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mansour", 
        "givenName": "Heba F.", 
        "id": "sg:person.014521170355.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014521170355.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Al Azhar University", 
          "id": "https://www.grid.ac/institutes/grid.411303.4", 
          "name": [
            "Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Abd El Rasoul", 
        "givenName": "Saleh", 
        "id": "sg:person.016007601766.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016007601766.82"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1208/s12249-009-9237-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000315201", 
          "https://doi.org/10.1208/s12249-009-9237-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10837450.2012.710238", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001756070"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4314/tjpr.v9i5.61063", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003251948"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4314/tjpr.v9i5.61063", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003251948"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/03639045.2015.1018274", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004683007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/03639040701377888", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004940265"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-008-9784-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005489333", 
          "https://doi.org/10.1007/s11095-008-9784-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.addr.2007.05.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008039331"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0939-6411(00)00076-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010715816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.21163", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010819060"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1011976615750", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013130879", 
          "https://doi.org/10.1023/a:1011976615750"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.24410", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017126325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1208/pt060479", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019722358", 
          "https://doi.org/10.1208/pt060479"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9343(01)00903-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023880052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2004.08.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024834659"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.aca.2007.07.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031376299"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2006.08.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034710156"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1248/cpb.54.1072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037498189"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10837450.2013.813543", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038059336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0378-5173(01)00891-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039124967"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.23539", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039258726"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4172/2329-9053.1000r1-001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046751510"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-006-9063-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048235358", 
          "https://doi.org/10.1007/s11095-006-9063-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-008-9721-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051503582", 
          "https://doi.org/10.1007/s11095-008-9721-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp1003674", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056212476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp1003674", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056212476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079798664", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-08", 
    "datePublishedReg": "2017-08-01", 
    "description": "The present study planed to develop new fast dissolving tablets (FDTs) of torsemide. Solid dispersions (SDs) of torsemide and sorbitol (3:1) or polyvinylpyrrolidone (PVP) k25 were prepared. The prepared SDs were evaluated for in-vitro dissolution. Fourier transform infrared spectroscopy and differential scanning calorimetry for SDs revealed no drug/excipient interactions and transformation of torsemide to the amorphous form. Torsemide/sorbitol SD was selected for formulation of torsemide FDTs by direct compression method. Box-Bhenken factorial design was employed to design 15 formulations using croscarmellose sodium and crospovidone at different concentrations. The response surface methodology was used to analyze the effect of changing these concentrations (independent variables) on disintegration time (Y1), percentage friability (Y2), and amount torsemide released at 10\u00a0min. The physical mixtures of torsemide and the used excipients were evaluated for angle of repose, Hausner's ratio, and Carr's index. The prepared FDTs tablets were evaluated for wetting and disintegration time, weight variation, drug content, percentage friability, thickness, hardness, and in vitro release. Based on the in-vitro results and factorial design characterization, F10 and F7 were selected for bioavailability studies following administration to Albino New Zealand rabbits. They showed significantly higher C max and (AUC0-12) and shorter T max than those obtained after administration of the corresponding ordinary commercial Torseretic \u00ae tablets. Stability study was conducted for F10 that showed good stability upon storage at 30\u00b0C/75% RH and 40\u00b0C/75% RH for 3\u00a0months.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1208/s12249-016-0697-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1023420", 
        "issn": [
          "1530-9932"
        ], 
        "name": "AAPS PharmSciTech", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "name": "Torsemide Fast Dissolving Tablets: Development, Optimization Using Box\u2013Bhenken Design and Response Surface Methodology, In Vitro Characterization, and Pharmacokinetic Assessment", 
    "pagination": "2168-2179", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "07636907b0513f2a3905372c1f725291b29655612b47b7a8c64bb7470b98b3e4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28050711"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100960111"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1208/s12249-016-0697-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001551151"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1208/s12249-016-0697-6", 
      "https://app.dimensions.ai/details/publication/pub.1001551151"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89812_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1208%2Fs12249-016-0697-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1208/s12249-016-0697-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1208/s12249-016-0697-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1208/s12249-016-0697-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1208/s12249-016-0697-6'


 

This table displays all metadata directly associated to this object as RDF triples.

241 TRIPLES      21 PREDICATES      71 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1208/s12249-016-0697-6 schema:about N07bcff89ff284089912257750351644d
2 N1f3005a1c93f4c54b132c34cb1930a85
3 N346162f608304485924264b5ac625918
4 N46def4e1be0a4bdab170539fd26ab7cc
5 N5c8d50e82e3548a785d77f40c32911fa
6 N6095aadcb28c4ee8ba43b333f97eafcf
7 N64f83fa6b82643a9933f927b3aa12954
8 N6abdacd016154c50a502fdf0d25ed22b
9 N6f724f73668e4cc9884b264d15828a87
10 N7b06885e92cc41a5934893ac4d5d9979
11 N8e7155ec987f468cb993f3f0e91cb61b
12 N93e743e16bbf4ca2a23a94bbb44eb8ae
13 Na322a4d8063d4e3aa43c5351656d5603
14 Na4b69b2b0fde455cb0d76283a02b7a70
15 Nab2ef9a90a6e44fcbef8841464a697f1
16 Ne789edf302c94ce0bfd104a0585d9716
17 Ned88aa0ae60d437cbe24ba55f517e81f
18 anzsrc-for:03
19 anzsrc-for:0306
20 schema:author N3030ca7e7ff14f20b393a524dfcc6e32
21 schema:citation sg:pub.10.1007/s11095-006-9063-9
22 sg:pub.10.1007/s11095-008-9721-1
23 sg:pub.10.1007/s11095-008-9784-z
24 sg:pub.10.1023/a:1011976615750
25 sg:pub.10.1208/pt060479
26 sg:pub.10.1208/s12249-009-9237-y
27 https://app.dimensions.ai/details/publication/pub.1079798664
28 https://doi.org/10.1002/jps.21163
29 https://doi.org/10.1002/jps.23539
30 https://doi.org/10.1002/jps.24410
31 https://doi.org/10.1016/j.aca.2007.07.011
32 https://doi.org/10.1016/j.addr.2007.05.006
33 https://doi.org/10.1016/j.ejpb.2006.08.018
34 https://doi.org/10.1016/j.ijpharm.2004.08.019
35 https://doi.org/10.1016/s0002-9343(01)00903-2
36 https://doi.org/10.1016/s0378-5173(01)00891-2
37 https://doi.org/10.1016/s0939-6411(00)00076-x
38 https://doi.org/10.1021/mp1003674
39 https://doi.org/10.1080/03639040701377888
40 https://doi.org/10.1248/cpb.54.1072
41 https://doi.org/10.3109/03639045.2015.1018274
42 https://doi.org/10.3109/10837450.2012.710238
43 https://doi.org/10.3109/10837450.2013.813543
44 https://doi.org/10.4172/2329-9053.1000r1-001
45 https://doi.org/10.4314/tjpr.v9i5.61063
46 schema:datePublished 2017-08
47 schema:datePublishedReg 2017-08-01
48 schema:description The present study planed to develop new fast dissolving tablets (FDTs) of torsemide. Solid dispersions (SDs) of torsemide and sorbitol (3:1) or polyvinylpyrrolidone (PVP) k25 were prepared. The prepared SDs were evaluated for in-vitro dissolution. Fourier transform infrared spectroscopy and differential scanning calorimetry for SDs revealed no drug/excipient interactions and transformation of torsemide to the amorphous form. Torsemide/sorbitol SD was selected for formulation of torsemide FDTs by direct compression method. Box-Bhenken factorial design was employed to design 15 formulations using croscarmellose sodium and crospovidone at different concentrations. The response surface methodology was used to analyze the effect of changing these concentrations (independent variables) on disintegration time (Y<sub>1</sub>), percentage friability (Y<sub>2</sub>), and amount torsemide released at 10 min. The physical mixtures of torsemide and the used excipients were evaluated for angle of repose, Hausner's ratio, and Carr's index. The prepared FDTs tablets were evaluated for wetting and disintegration time, weight variation, drug content, percentage friability, thickness, hardness, and in vitro release. Based on the in-vitro results and factorial design characterization, F10 and F7 were selected for bioavailability studies following administration to Albino New Zealand rabbits. They showed significantly higher C <sub>max</sub> and (AUC<sub>0-12</sub>) and shorter T <sub>max</sub> than those obtained after administration of the corresponding ordinary commercial Torseretic ® tablets. Stability study was conducted for F10 that showed good stability upon storage at 30°C/75% RH and 40°C/75% RH for 3 months.
49 schema:genre research_article
50 schema:inLanguage en
51 schema:isAccessibleForFree false
52 schema:isPartOf N30802974cf144b24b9dbf3eaf42df941
53 N81b164f8457f403cb0e534d82c24b571
54 sg:journal.1023420
55 schema:name Torsemide Fast Dissolving Tablets: Development, Optimization Using Box–Bhenken Design and Response Surface Methodology, In Vitro Characterization, and Pharmacokinetic Assessment
56 schema:pagination 2168-2179
57 schema:productId N2a3334a2a6e142d08aae8672c6ca5baf
58 N4791114c49204067bc76142a4bafaa40
59 N7f102897b990463a94919d7c696e6251
60 Ncf81e5438e73411695f20638db86b3c4
61 Ne72072c852674ba183a60c54b4dd79c2
62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001551151
63 https://doi.org/10.1208/s12249-016-0697-6
64 schema:sdDatePublished 2019-04-11T09:57
65 schema:sdLicense https://scigraph.springernature.com/explorer/license/
66 schema:sdPublisher Nc8d7597cf7174171ad57883170dc799b
67 schema:url https://link.springer.com/10.1208%2Fs12249-016-0697-6
68 sgo:license sg:explorer/license/
69 sgo:sdDataset articles
70 rdf:type schema:ScholarlyArticle
71 N07bcff89ff284089912257750351644d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Sweetening Agents
73 rdf:type schema:DefinedTerm
74 N14fa11eacb54443584f2c485f9a2a2b7 rdf:first sg:person.016007601766.82
75 rdf:rest rdf:nil
76 N1f3005a1c93f4c54b132c34cb1930a85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Torsemide
78 rdf:type schema:DefinedTerm
79 N2479a9bfea0f419d8f2e6f6815019996 rdf:first sg:person.014521170355.19
80 rdf:rest N14fa11eacb54443584f2c485f9a2a2b7
81 N2a3334a2a6e142d08aae8672c6ca5baf schema:name pubmed_id
82 schema:value 28050711
83 rdf:type schema:PropertyValue
84 N3030ca7e7ff14f20b393a524dfcc6e32 rdf:first Nc46a4e9ea37646a8ac69b6deb814e837
85 rdf:rest N9fcc3cb85f2a4e8c943950563704c640
86 N30802974cf144b24b9dbf3eaf42df941 schema:volumeNumber 18
87 rdf:type schema:PublicationVolume
88 N346162f608304485924264b5ac625918 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Antihypertensive Agents
90 rdf:type schema:DefinedTerm
91 N46def4e1be0a4bdab170539fd26ab7cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Animals
93 rdf:type schema:DefinedTerm
94 N4791114c49204067bc76142a4bafaa40 schema:name readcube_id
95 schema:value 07636907b0513f2a3905372c1f725291b29655612b47b7a8c64bb7470b98b3e4
96 rdf:type schema:PropertyValue
97 N5c8d50e82e3548a785d77f40c32911fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Spectroscopy, Fourier Transform Infrared
99 rdf:type schema:DefinedTerm
100 N6095aadcb28c4ee8ba43b333f97eafcf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Rabbits
102 rdf:type schema:DefinedTerm
103 N64f83fa6b82643a9933f927b3aa12954 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Solubility
105 rdf:type schema:DefinedTerm
106 N6abdacd016154c50a502fdf0d25ed22b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Povidone
108 rdf:type schema:DefinedTerm
109 N6f724f73668e4cc9884b264d15828a87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Biological Availability
111 rdf:type schema:DefinedTerm
112 N7b06885e92cc41a5934893ac4d5d9979 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Sulfonamides
114 rdf:type schema:DefinedTerm
115 N7f102897b990463a94919d7c696e6251 schema:name nlm_unique_id
116 schema:value 100960111
117 rdf:type schema:PropertyValue
118 N81b164f8457f403cb0e534d82c24b571 schema:issueNumber 6
119 rdf:type schema:PublicationIssue
120 N84e81bf9c7b04f928a32ae046368904b schema:affiliation https://www.grid.ac/institutes/grid.412659.d
121 schema:familyName Ahmed
122 schema:givenName Mahmoud M.
123 rdf:type schema:Person
124 N8e7155ec987f468cb993f3f0e91cb61b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Calorimetry, Differential Scanning
126 rdf:type schema:DefinedTerm
127 N93e743e16bbf4ca2a23a94bbb44eb8ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Carboxymethylcellulose Sodium
129 rdf:type schema:DefinedTerm
130 N9fcc3cb85f2a4e8c943950563704c640 rdf:first N84e81bf9c7b04f928a32ae046368904b
131 rdf:rest N2479a9bfea0f419d8f2e6f6815019996
132 Na322a4d8063d4e3aa43c5351656d5603 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Excipients
134 rdf:type schema:DefinedTerm
135 Na4b69b2b0fde455cb0d76283a02b7a70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Pharmaceutic Aids
137 rdf:type schema:DefinedTerm
138 Nab2ef9a90a6e44fcbef8841464a697f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Sorbitol
140 rdf:type schema:DefinedTerm
141 Nc46a4e9ea37646a8ac69b6deb814e837 schema:affiliation https://www.grid.ac/institutes/grid.411303.4
142 schema:familyName El-Shenawy
143 schema:givenName Ahmed A.
144 rdf:type schema:Person
145 Nc8d7597cf7174171ad57883170dc799b schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 Ncf81e5438e73411695f20638db86b3c4 schema:name dimensions_id
148 schema:value pub.1001551151
149 rdf:type schema:PropertyValue
150 Ne72072c852674ba183a60c54b4dd79c2 schema:name doi
151 schema:value 10.1208/s12249-016-0697-6
152 rdf:type schema:PropertyValue
153 Ne789edf302c94ce0bfd104a0585d9716 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Drug Compounding
155 rdf:type schema:DefinedTerm
156 Ned88aa0ae60d437cbe24ba55f517e81f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Tablets
158 rdf:type schema:DefinedTerm
159 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
160 schema:name Chemical Sciences
161 rdf:type schema:DefinedTerm
162 anzsrc-for:0306 schema:inDefinedTermSet anzsrc-for:
163 schema:name Physical Chemistry (incl. Structural)
164 rdf:type schema:DefinedTerm
165 sg:journal.1023420 schema:issn 1530-9932
166 schema:name AAPS PharmSciTech
167 rdf:type schema:Periodical
168 sg:person.014521170355.19 schema:affiliation https://www.grid.ac/institutes/grid.411806.a
169 schema:familyName Mansour
170 schema:givenName Heba F.
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014521170355.19
172 rdf:type schema:Person
173 sg:person.016007601766.82 schema:affiliation https://www.grid.ac/institutes/grid.411303.4
174 schema:familyName Abd El Rasoul
175 schema:givenName Saleh
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016007601766.82
177 rdf:type schema:Person
178 sg:pub.10.1007/s11095-006-9063-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048235358
179 https://doi.org/10.1007/s11095-006-9063-9
180 rdf:type schema:CreativeWork
181 sg:pub.10.1007/s11095-008-9721-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051503582
182 https://doi.org/10.1007/s11095-008-9721-1
183 rdf:type schema:CreativeWork
184 sg:pub.10.1007/s11095-008-9784-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1005489333
185 https://doi.org/10.1007/s11095-008-9784-z
186 rdf:type schema:CreativeWork
187 sg:pub.10.1023/a:1011976615750 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013130879
188 https://doi.org/10.1023/a:1011976615750
189 rdf:type schema:CreativeWork
190 sg:pub.10.1208/pt060479 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019722358
191 https://doi.org/10.1208/pt060479
192 rdf:type schema:CreativeWork
193 sg:pub.10.1208/s12249-009-9237-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1000315201
194 https://doi.org/10.1208/s12249-009-9237-y
195 rdf:type schema:CreativeWork
196 https://app.dimensions.ai/details/publication/pub.1079798664 schema:CreativeWork
197 https://doi.org/10.1002/jps.21163 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010819060
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1002/jps.23539 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039258726
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1002/jps.24410 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017126325
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/j.aca.2007.07.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031376299
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1016/j.addr.2007.05.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008039331
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1016/j.ejpb.2006.08.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034710156
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1016/j.ijpharm.2004.08.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024834659
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1016/s0002-9343(01)00903-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023880052
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1016/s0378-5173(01)00891-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039124967
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1016/s0939-6411(00)00076-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010715816
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1021/mp1003674 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056212476
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1080/03639040701377888 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004940265
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1248/cpb.54.1072 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037498189
222 rdf:type schema:CreativeWork
223 https://doi.org/10.3109/03639045.2015.1018274 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004683007
224 rdf:type schema:CreativeWork
225 https://doi.org/10.3109/10837450.2012.710238 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001756070
226 rdf:type schema:CreativeWork
227 https://doi.org/10.3109/10837450.2013.813543 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038059336
228 rdf:type schema:CreativeWork
229 https://doi.org/10.4172/2329-9053.1000r1-001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046751510
230 rdf:type schema:CreativeWork
231 https://doi.org/10.4314/tjpr.v9i5.61063 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003251948
232 rdf:type schema:CreativeWork
233 https://www.grid.ac/institutes/grid.411303.4 schema:alternateName Al Azhar University
234 schema:name Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt
235 rdf:type schema:Organization
236 https://www.grid.ac/institutes/grid.411806.a schema:alternateName Minia University
237 schema:name Department of Pharmaceutics, Faculty of Pharmacy, Minia University, P.O.Box 61111, Minia, Egypt
238 rdf:type schema:Organization
239 https://www.grid.ac/institutes/grid.412659.d schema:alternateName Sohag University
240 schema:name Department of Pharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, Sohag University, Sohag, Egypt
241 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...